| pubmed-article:19785656 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19785656 | lifeskim:mentions | umls-concept:C0031330 | lld:lifeskim |
| pubmed-article:19785656 | lifeskim:mentions | umls-concept:C0034493 | lld:lifeskim |
| pubmed-article:19785656 | lifeskim:mentions | umls-concept:C1135918 | lld:lifeskim |
| pubmed-article:19785656 | lifeskim:mentions | umls-concept:C0221464 | lld:lifeskim |
| pubmed-article:19785656 | lifeskim:mentions | umls-concept:C2709248 | lld:lifeskim |
| pubmed-article:19785656 | lifeskim:mentions | umls-concept:C0031715 | lld:lifeskim |
| pubmed-article:19785656 | lifeskim:mentions | umls-concept:C0439799 | lld:lifeskim |
| pubmed-article:19785656 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:19785656 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19785656 | pubmed:dateCreated | 2009-10-28 | lld:pubmed |
| pubmed-article:19785656 | pubmed:abstractText | Ca(2+)-activated Cl(-) currents (I(Cl(Ca))) in arterial smooth muscle cells are inhibited by phosphorylation. The Ca(2+)-activated Cl(-) channel (Cl(Ca)) blocker niflumic acid (NFA) produces a paradoxical dual effect on I(Cl(Ca)), causing stimulation or inhibition at potentials below or above 0 mV respectively. We tested whether the effects of NFA on I(Cl(Ca)) were modulated by phosphorylation. | lld:pubmed |
| pubmed-article:19785656 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19785656 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19785656 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19785656 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19785656 | pubmed:issn | 1476-5381 | lld:pubmed |
| pubmed-article:19785656 | pubmed:author | pubmed-author:LeblancNN | lld:pubmed |
| pubmed-article:19785656 | pubmed:author | pubmed-author:GreenwoodI... | lld:pubmed |
| pubmed-article:19785656 | pubmed:author | pubmed-author:WiwcharMM | lld:pubmed |
| pubmed-article:19785656 | pubmed:author | pubmed-author:AyonRR | lld:pubmed |
| pubmed-article:19785656 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19785656 | pubmed:volume | 158 | lld:pubmed |
| pubmed-article:19785656 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19785656 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19785656 | pubmed:pagination | 1356-65 | lld:pubmed |
| pubmed-article:19785656 | pubmed:dateRevised | 2010-11-2 | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:meshHeading | pubmed-meshheading:19785656... | lld:pubmed |
| pubmed-article:19785656 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19785656 | pubmed:articleTitle | Phosphorylation alters the pharmacology of Ca(2+)-activated Cl channels in rabbit pulmonary arterial smooth muscle cells. | lld:pubmed |
| pubmed-article:19785656 | pubmed:affiliation | Department of Pharmacology, Center of Biomedical Research Excellence (COBRE), University of Nevada School of Medicine, Reno, NV 89557-0270, USA. | lld:pubmed |
| pubmed-article:19785656 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19785656 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:19785656 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19785656 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19785656 | lld:pubmed |
